HER2/neu Testing in Breast Carcinoma. Concordance Study Fluorescent In Situ Hybridization (FISH) vs. Chromogenic In Situ Hybridization (CISH)

被引：0
|
作者：
Elavathil, L.
Dhesy, B.
Wiernikowski, J.
Browning, D.
Akhtar-Danesh, N.
Hanna, W.
机构：
[1] McMaster Univ, Hamilton, ON, Canada
[2] Juravinski Canc Ctr, Hamilton, ON, Canada
[3] Univ Toronto, Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada
来源：
MODERN PATHOLOGY | 2009年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
160
引用
收藏
页码：38A / 38A
页数：1
相关论文
共 50 条
  • [31] Determination of human epidermal growth factor receptor 2 (HER2) amplification using fluorescence in situ hybridization (FISH), chromogenic in situ hybridization (CISH) and automated silver in situ hybridization (SISH)
    Munawer, Nurhayati H.
    Ali, Siti Aishah Md
    Zain, Reena Md
    Ali, Munirah Mohd
    Muhammad, Rohaizak
    Masir, Noraidah
    Florence, Chandramaya S.
    Mohamed, Rafie K.
    Arbi, Asmiati
    Akmal, Sharifah Noor
    Das, Srijit
    AFRICAN JOURNAL OF BIOTECHNOLOGY, 2011, 10 (73): : 16429 - 16436
  • [32] HER2 positivity in breast carcinoma: A comparison of chromogenic in situ hybridization with fluorescence in situ hybridization in tissue microarrays, with targeted evaluation of intratumoral heterogeneity by in situ hybridization
    Loring, P
    Cummins, R
    O'Grady, A
    Kay, EW
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2005, 13 (02) : 194 - 200
  • [33] Her2 amplification - Correlation of chromogenic in situ hybridization with immunohistochemistry and fluorescence in situ hybridization
    Wixom, CR
    Albers, EA
    Weidner, N
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2004, 12 (03) : 248 - 251
  • [34] Chromogenic in-situ hybridization:: a viable alternative to fluorescence in-situ hybridization in the HER2 testing algorithm
    Hanna, WM
    Kwok, K
    MODERN PATHOLOGY, 2006, 19 (04) : 481 - 487
  • [35] Comparison of Fluorescence In Situ Hybridization and Chromogenic In Situ Hybridization for Low and High Throughput HER2 Genetic Testing
    Poulsen, Tim S.
    Espersen, Maiken L. M.
    Kofoed, Vibeke
    Dabetic, Tanja
    Hogdall, Estrid
    Balslev, Eva
    INTERNATIONAL JOURNAL OF BREAST CANCER, 2013, 2013
  • [36] Prognostic relevance of HER-2/neu status determined by Immunohistochemistry, Chromogenic in Situ Hybridization (CISH) and FISH in Lymph-node negative breast carcinoma
    Peiro, Gloria
    Adrover, Encarna
    Alenda, Cristina
    Peiro, Francisca
    Aranda, Ignacio
    ANNALS OF ONCOLOGY, 2004, 15 : 62 - 62
  • [37] Resolving Equivocal HER2 Status in Breast Cancer by Automated and Quantitative RNA Chromogenic In Situ Hybridization (CISH)
    Wang, Z.
    Bui, S.
    Wang, H.
    Su, N.
    Ma, X-J
    Luo, Y.
    Tubbs, R. R.
    LABORATORY INVESTIGATION, 2012, 92 : 72A - 72A
  • [38] Comparison of automated silver enhanced in situ hybridization (SISH) and fluorescent in situ hybridization (FISH) for assessment of Her2/neu gene status in invasive breast carcinomas
    Kahn, H. J.
    Ghorab, Z.
    Kwok, K.
    Hanna, W.
    MODERN PATHOLOGY, 2008, 21 : 40A - 40A
  • [39] Comparison of automated silver enhanced in situ hybridization (SISH) and fluorescent in situ hybridization (FISH) for assessment of her2/neu gene status in invasive breast carcinomas
    Kahn, H. J.
    Ghorab, Z.
    Kwok, K.
    Hanna, W.
    LABORATORY INVESTIGATION, 2008, 88 : 40A - 40A
  • [40] Resolving Equivocal HER2 Status in Breast Cancer by Automated and Quantitative RNA Chromogenic In Situ Hybridization (CISH)
    Wang, Z.
    Bui, S.
    Wang, H.
    Su, N.
    Ma, X-J
    Luo, Y.
    Tubbs, R. R.
    MODERN PATHOLOGY, 2012, 25 : 72A - 72A
12345